Scopoletin

Scopoletin

SCHEMBL21114360

COc1cc2ccc(=O)oc2cc1O.COc1cc2ccc(=O)oc2cc1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA9 Q16790 10/20 1.00
CA12 O43570 8/20 1.00
KDM4E B2RXH2 8/20 1.00
ALDH1A1 P00352 8/20 1.00
HPGD P15428 8/20 1.00
HSD17B10 Q99714 7/20 1.00
CA1 P00915 6/20 1.00
CA7 P43166 6/20 1.00
MCL1 Q07820 5/20 1.00
CA13 Q8N1Q1 5/20 1.00
CASP1 P29466 5/20 1.00
CASP7 P55210 5/20 1.00
AKR1B1 P15121 4/20 1.00
CYP1A2 P05177 2/20 1.00
GLA P06280 2/20 1.00
GAA P10253 2/20 1.00
HIF1A Q16665 2/20 1.00
ERAP1 Q9NZ08 2/20 1.00
MEN1 O00255 2/20 1.00
KMT2A Q03164 2/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Scopoletin SCHEMBL29712325 1.00 CA9 (1.00) CA9CA12KDM4EALDH1A1HPGD
Scopoletin SCHEMBL147702 1.00 CA9 (1.00) CA9CA12KDM4EALDH1A1HPGD
Scopoletin SCHEMBL5060518 0.97 CA9 (0.94) CA9CA12KDM4EALDH1A1HPGD
Isoscopoletin SCHEMBL2790887 0.95 CA9 (1.00) CA9CA12KDM4EALDH1A1HPGD
Isoscopoletin SCHEMBL30640526 0.95 CA9 (1.00) CA9CA12KDM4EALDH1A1HPGD
Scopoletin SCHEMBL9949053 0.91 CA9 (0.83) CA9CA12KDM4EALDH1A1HPGD
Scoparone SCHEMBL29714063 0.88 MCL1 (1.00) CA9CA12KDM4EALDH1A1HPGD
Scoparone SCHEMBL240777 0.88 MCL1 (1.00) CA9CA12KDM4EALDH1A1HPGD
Scoparone SCHEMBL27678756 0.84 MCL1 (0.93) CA9CA12KDM4EALDH1A1HPGD
SCHEMBL22273624 0.83 KDM4E (0.71) CA9CA12KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190214145-A1 Method and systems for creating and screening patient metabolite profile to diagnose current medical condition, diagnose current treatment state and recommend new treatment regimen KUREK ITZHAK (US) 2019-07-11 US disclosed